|
|
Blood, 15 December 2005, Vol. 106, No. 13, pp. 4339-4344.
Prepublished online as a Blood First Edition Paper on August 2, 2005; DOI 10.1182/blood-2005-06-2341.
Previous Article | Next Article 
Submitted June 13, 2005
Accepted July 27, 2005
Rescue of 'crippled' germinal center B cells from apoptosis by Epstein-Barr virus
Christoph Mancao, Markus Altmann, Berit Jungnickel, and Wolfgang Hammerschmidt*
Department of Gene Vectors, GSF - National Research Center for Environment and Health, Munich, Germany
Institute for Clinical Molecular Biology and Tumor Genetics, GSF - National Research Center for Environment and Health, Munich, Germany
* Corresponding author; email: hammerschmidt{at}gsf.de.
Epstein-Barr virus (EBV) is associated with B cell lymphomas such as Hodgkin lymphoma, Burkitt lymphoma, and post-transplant lymphoma, which originate from clonal germinal center (GC) B cells. During the process of somatic hypermutation, GC B cells can acquire deleterious or nonsense mutations in the heavy and light immunoglobulin genes. Such mutations abrogate the cell surface expression of the B cell receptor (BCR), which results in the elimination of these non-functional B cells by immediate apoptosis. EBV encodes several latent genes, among them latent membrane protein 1 (LMP1) and LMP2A, which are regularly expressed in EBV-positive Hodgkin lymphoma and post-transplant lymphomas. Since LMP1 and LMP2A mimic the function of two key receptors on B cells, CD40 and BCR, respectively, we wanted to learn whether EBV infection can rescue pro-apoptotic GC B cells with crippling mutations in the heavy chain immunoglobulin locus from apoptosis. We show here that BCR-negative GC B cells readily enter the cell cycle upon infection with EBV in vitro and yield clonal lymphoblastoid cell lines that are incapable of expressing a functional BCR because the rearranged and formerly functional heavy chain immunoglobulin alleles carry deleterious mutations. Our findings imply an important role for EBV in the process of lymphomagenesis in certain cases of Hodgkin lymphoma and post-transplant lymphomas.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Articles in Blood Online:
-
EBV meets BCR- B cells
- Daniel Re
Blood 2005 106: 4020-4021.
[Full Text]
[PDF]
-
Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas
- Dörte Bechtel, Julia Kurth, Claus Unkel, and Ralf Küppers
Blood 2005 106: 4345-4350.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
K. T. Bieging, A. C. Amick, and R. Longnecker
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis
PNAS,
October 20, 2009;
106(42):
17945 - 17950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M'kacher, L. Andreoletti, S. Flamant, F. Milliat, T. Girinsky, J. Dossou, D. Violot, E. Assaf, B. Clausse, S. Koscielny, et al.
JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome
Ann. Onc.,
October 13, 2009;
(2009)
mdp375v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz
HIV-associated lymphomas and gamma-herpesviruses
Blood,
February 5, 2009;
113(6):
1213 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Kapatai and P Murray
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma
J. Clin. Pathol.,
December 1, 2007;
60(12):
1342 - 1349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kuppers
Viral mimic for B-cell survival
Blood,
November 15, 2007;
110(10):
3494 - 3495.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mancao and W. Hammerschmidt
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Blood,
November 15, 2007;
110(10):
3715 - 3721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hjalgrim, K. Ekstrom-Smedby, K. Rostgaard, R.-M. Amini, D. Molin, S. Hamilton-Dutoit, C. Schollkopf, E. T. Chang, E. Ralfkiaer, H.-O. Adami, et al.
Cigarette Smoking and Risk of Hodgkin Lymphoma: A Population-Based Case-Control Study
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2007;
16(8):
1561 - 1566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Rechsteiner, C. Berger, M. Weber, J. A. Sigrist, D. Nadal, and M. Bernasconi
Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells
J. Gen. Virol.,
May 1, 2007;
88(5):
1454 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-C. Chuang, J.-D. Lay, S.-E. Chuang, W.-C. Hsieh, Y. Chang, and I.-J. Su
Epstein-Barr Virus (EBV) Latent Membrane Protein-1 Down-Regulates Tumor Necrosis Factor-{alpha} (TNF-{alpha}) Receptor-1 and Confers Resistance to TNF-{alpha}-Induced Apoptosis in T Cells: Implication for the Progression to T-Cell Lymphoma in EBV-Associated Hemophagocytic Syndrome
Am. J. Pathol.,
May 1, 2007;
170(5):
1607 - 1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hjalgrim, K. Ekstrom Smedby, K. Rostgaard, D. Molin, S. Hamilton-Dutoit, E. T. Chang, E. Ralfkiaer, C. Sundstrom, H.-O. Adami, B. Glimelius, et al.
Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma
Cancer Res.,
March 1, 2007;
67(5):
2382 - 2388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Ambinder
Epstein-Barr Virus and Hodgkin Lymphoma
Hematology,
January 1, 2007;
2007(1):
204 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Natkunam, E. D. Hsi, P. Aoun, S. Zhao, P. Elson, B. Pohlman, H. Naushad, M. Bast, R. Levy, and I. S. Lossos
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival
Blood,
January 1, 2007;
109(1):
298 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Snow, S. L. Lambert, Y. Natkunam, C. O. Esquivel, S. M. Krams, and O. M. Martinez
EBV Can Protect Latently Infected B Cell Lymphomas from Death Receptor-Induced Apoptosis.
J. Immunol.,
September 1, 2006;
177(5):
3283 - 3293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Brinkmann and T. F. Schulz
Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.
J. Gen. Virol.,
May 1, 2006;
87(Pt 5):
1047 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chaganti, A. I. Bell, N. B. Pastor, A. E. Milner, M. Drayson, J. Gordon, and A. B. Rickinson
Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes
Blood,
December 15, 2005;
106(13):
4249 - 4252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bechtel, J. Kurth, C. Unkel, and R. Kuppers
Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas
Blood,
December 15, 2005;
106(13):
4345 - 4350.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|